LifeVantage insider filing: PRSUs converted; Steven Fife sold shares at $13.10
Rhea-AI Filing Summary
Steven R. Fife, President and CEO and director of Lifevantage Corp (LFVN), reported insider transactions on 08/31/2025. Two tranches of previously granted performance restricted stock units converted into common stock: 90,718 shares (granted 08/24/2023) and 108,960 shares (granted 08/26/2024). Those PRSUs convert one-for-one into common shares and were reported as acquired at $0 under Rule 16 reporting codes. Separately, 98,177 shares were disposed of at a reported price of $13.10, leaving the reporting person with 761,001 and 859,178 total shares following the respective transactions as shown on the form.
Positive
- Vested PRSUs converted one-for-one into common shares, reflecting compensation realization rather than external purchase
- Substantial remaining insider ownership after transactions (reported beneficial ownership figures remain high)
Negative
- Insider sale of 98,177 shares at $13.10 could be perceived as insider liquidity or diversification without stated context
- Form does not state whether the sale was executed pursuant to a pre-established trading plan (Rule 10b5-1)
Insights
TL;DR: Insider received vested PRSUs that converted to shares and executed a significant sale; overall disclosure is routine.
These filings show time- and performance-based PRSUs vesting and converting one-for-one into common stock, which is common compensation for executives and not an open-market purchase. The sale of 98,177 shares at $13.10 is material in size but not accompanied by explanation (e.g., liquidity needs, diversification, or pre-arranged trading plan). Combined activity increases reported insider liquidity while leaving the CEO with substantial residual holdings, consistent with executive compensation realization rather than a change in control or strategy.
TL;DR: Disclosure aligns with standard Form 4 practice; PRSU vesting and a concurrent share sale are properly reported.
The Form 4 discloses grants from 2023 and 2024 that vested and converted into common stock, and a contemporaneous disposition. Reporting includes dates, quantities, and prices as required. There is no indication within the form of Rule 10b5-1 reliance or other trading-plan notation, and the filing was signed by a power of attorney. For governance review, the transactions are transparent but lack context on whether the sale was pre-planned.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Stock Units | 90,718 | $0.00 | -- |
| Exercise | Performance Restricted Stock Units | 108,960 | $0.00 | -- |
| Exercise | Common Stock | 90,718 | $0.00 | -- |
| Exercise | Common Stock | 108,960 | $0.00 | -- |
| Tax Withholding | Common Stock | 98,177 | $13.10 | $1.29M |
Footnotes (1)
- On August 24, 2023, the reporting person was granted Performance Restricted Stock Units ("PRSUs") which vest upon achievement of previously established time-based and financial performance criteria. On August 26, 2024, the reporting person was granted PRSUs which vest upon achievement of previously established time-based and financial performance criteria. PRSUs convert into common stock on a one-for-one basis.
